Our Medical Advisory Board consists of
surgeons of the highest calibre who advise us at each point in research, product development, marketing and clinical – extending well beyond the touchpoints mandated by legislation and standards.
Our Medical Advisory Board consists of
surgeons of the highest calibre who advise us at each point in research, product development, marketing and clinical – extending well beyond the touchpoints mandated by legislation and standards.
Tom joined Nova Eye Medical in 2020. Prior to Nova Eye Medical, Tom served as the Chief Executive Officer of Ellex Medical from 2011 to 2019. Tom has close to 30years of senior executive experience across arange of management and advisory roles in Australia and the United States, including Non-Executive Director at Sparc Technologies Ltd., Non-Executive Director at Autodom Ltd. and Managing Director&General Manager at Tenix Lads Corp. Pty Ltd. His experience includes listed company equity capital markets in Australia and the USA, sales management, customer relationship management (both private business and Australian, US and other governments) and financial reporting. Tom is amember of The Institute of Chartered Accountants in Australia and holds aBachelor of Economics from the University of Adelaide,Australia.
Kate joined Nova Eye Medical in 2020. She started in ophthalmology in 2001 with Ellex Medical and has extensive experience across consumable devices and surgical capital equipment, covering both B2B and B2C environments. During her time in the ophthalmic space, Kate has directed marketing and sales strategies to support various initiatives, including company acquisitions and new product launch. In addition to directing the Company’s various commercial programs in both existing and emerging markets, Kate is responsible for our clinical study program (both company-sponsored and investigator-initiated), market access and business development. Kate holds a Bachelor of Commerce and a Bachelor of Economics from The University of Adelaide, Australia.
Joe joined Nova Eye Medical in 2020. His career in ophthalmology dates back to 2001, over which time he has held numerous roles with Allergan and Abbott Medical Optics covering both consumable devices and surgical capital equipment. Joe is astrong advocate for best-in-class surgical training, having previously developed and implemented the Abbott Teaching Institution Program in the U.S. and Canada. He also brings solid, first-hand experience in the minimally invasive glaucoma surgery (MIGS) market, having aunched the XEN MIGS Gel Stent into the U.S. market. Joe holds aBachelor of Business Administration and Management from Pennwest California, USA, and aMaster of Science from Oakland City University, USA. He is amember of the American Glaucoma Society (AGS) Foundation AdvisoryBoard.
